The persistent, often debilitating symptom burden of Long COVID remains mechanistically poorly understood, yet identifying biological correlates of symptom severity could open new diagnostic and therapeutic avenues. This preprint adds a nuanced piece to that puzzle by linking a commonly overlooked herpesvirus — HHV-6 — to the degree of Long COVID severity, even in the absence of gross differences in viral shedding between groups.
The study enrolled 90 participants — 45 with Long COVID and 45 age- and sex-matched controls — collecting saliva at six time points across two consecutive days. Using multiplex quantitative PCR, researchers screened for EBV, HSV-1/2, human cytomegalovirus, and HHV-6 A/B, alongside salivary cortisol, testosterone, and estradiol. Notably, salivary HHV-6 DNA levels were not elevated in Long COVID participants as a group compared to controls, but within the Long COVID cohort, higher HHV-6 viral loads were positively associated with a composite Long COVID propensity score and with validated anxiety and depression measures. EBV shedding showed no similar within-group gradient. Both EBV and HHV-6 DNA were detected at highest levels in early-morning samples, consistent with known circadian patterns of herpesvirus reactivation.
This finding matters for several reasons. First, it shifts the frame from simple presence-or-absence of herpesvirus reactivation to viral load magnitude as a potential severity biomarker. HHV-6 has a unique biological property — it can integrate into host chromosomes — making its reactivation dynamics distinct from EBV. The neurotropic character of HHV-6 is also plausible mechanistic context for its association with anxiety and depression scores, though causality cannot be established from this observational design. The study's 90-person sample is modest, the data are cross-sectional, and salivary viral DNA reflects shedding rather than confirmed systemic reactivation. As a preprint, findings have not yet undergone peer review. Nonetheless, the granular multi-timepoint saliva methodology is a meaningful methodological contribution, and the HHV-6 severity gradient warrants replication in larger, longitudinal cohorts.